Literature DB >> 17285342

Differential morphology and composition of inclusions in the R6/2 mouse and PC12 cell models of Huntington's disease.

Jonathan Wanderer1, A Jennifer Morton.   

Abstract

The histological hallmark feature of Huntington's disease (HD) and other polyglutamine repeat diseases is the presence of intracellular inclusions. Much work has been devoted to trying to determine the relationship between inclusion formation and neuronal injury. However, little attention has been paid to the variability and characteristics of inclusions themselves. Here, we characterize the morphological and biochemical composition of inclusions in both a transgenic mouse model (R6/2 line) and an inducible cell culture model of HD (iPC12Q74). We identified several morphologically distinct kinds of inclusions in different locations (nuclei, cytoplasm and cellular processes). Ubiquitin colocalized completely with all of these inclusions in both the iPC12Q72 and R6/2 models. In the inclusions in iPC12Q74 cells, the 20S and 11S proteasome subunits colocalized variably, and the 19S subunit did not colocalize at all. In inclusions in R6/2 mouse neurons, the 20S subunit colocalized completely, but neither the 11S nor the 19S subunits colocalized at all. While the role of inclusions in the pathogenesis of HD continues to be debated, we suggest that the content and structure of inclusions vary considerably, not only from cell to cell but even within individual cells. Their role in the pathogenesis of HD is likely to depend on their location as well as their composition.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17285342     DOI: 10.1007/s00418-007-0272-z

Source DB:  PubMed          Journal:  Histochem Cell Biol        ISSN: 0948-6143            Impact factor:   2.531


  38 in total

1.  Accumulation of mutant huntingtin fragments in aggresome-like inclusion bodies as a result of insufficient protein degradation.

Authors:  S Waelter; A Boeddrich; R Lurz; E Scherzinger; G Lueder; H Lehrach; E E Wanker
Journal:  Mol Biol Cell       Date:  2001-05       Impact factor: 4.138

2.  Global impairment of the ubiquitin-proteasome system by nuclear or cytoplasmic protein aggregates precedes inclusion body formation.

Authors:  Eric J Bennett; Neil F Bence; Rajadas Jayakumar; Ron R Kopito
Journal:  Mol Cell       Date:  2005-02-04       Impact factor: 17.970

Review 3.  Diseases of unstable repeat expansion: mechanisms and common principles.

Authors:  Jennifer R Gatchel; Huda Y Zoghbi
Journal:  Nat Rev Genet       Date:  2005-10       Impact factor: 53.242

4.  Effects of heat shock, heat shock protein 40 (HDJ-2), and proteasome inhibition on protein aggregation in cellular models of Huntington's disease.

Authors:  A Wyttenbach; J Carmichael; J Swartz; R A Furlong; Y Narain; J Rankin; D C Rubinsztein
Journal:  Proc Natl Acad Sci U S A       Date:  2000-03-14       Impact factor: 11.205

5.  Huntingtin-encoded polyglutamine expansions form amyloid-like protein aggregates in vitro and in vivo.

Authors:  E Scherzinger; R Lurz; M Turmaine; L Mangiarini; B Hollenbach; R Hasenbank; G P Bates; S W Davies; H Lehrach; E E Wanker
Journal:  Cell       Date:  1997-08-08       Impact factor: 41.582

6.  Mice transgenic for the Huntington's disease mutation are resistant to chronic 3-nitropropionic acid-induced striatal toxicity.

Authors:  M A Hickey; A J Morton
Journal:  J Neurochem       Date:  2000-11       Impact factor: 5.372

Review 7.  Pathogenesis of polyglutamine disorders: aggregation revisited.

Authors:  Andrej Michalik; Christine Van Broeckhoven
Journal:  Hum Mol Genet       Date:  2003-10-15       Impact factor: 6.150

8.  Aggregated polyglutamine peptides delivered to nuclei are toxic to mammalian cells.

Authors:  Wen Yang; John R Dunlap; Richard B Andrews; Ronald Wetzel
Journal:  Hum Mol Genet       Date:  2002-11-01       Impact factor: 6.150

9.  Calmodulin regulates transglutaminase 2 cross-linking of huntingtin.

Authors:  Gina M Zainelli; Christopher A Ross; Juan C Troncoso; John K Fitzgerald; Nancy A Muma
Journal:  J Neurosci       Date:  2004-02-25       Impact factor: 6.167

10.  Huntingtin forms toxic NH2-terminal fragment complexes that are promoted by the age-dependent decrease in proteasome activity.

Authors:  Hui Zhou; Fengli Cao; Zhishan Wang; Zhao-Xue Yu; Huu-Phuc Nguyen; Joy Evans; Shi-Hua Li; Xiao-Jiang Li
Journal:  J Cell Biol       Date:  2003-10-13       Impact factor: 10.539

View more
  8 in total

Review 1.  Recent progress in histochemistry.

Authors:  Christian Zuber; Douglas J Taatjes; Jürgen Roth
Journal:  Histochem Cell Biol       Date:  2007-10-31       Impact factor: 4.304

Review 2.  State-of-the-art technologies, current opinions and developments, and novel findings: news from the field of histochemistry and cell biology.

Authors:  Esther Asan; Detlev Drenckhahn
Journal:  Histochem Cell Biol       Date:  2008-11-05       Impact factor: 4.304

Review 3.  Polyglutamine Aggregation in Huntington Disease: Does Structure Determine Toxicity?

Authors:  Guylaine Hoffner; Philippe Djian
Journal:  Mol Neurobiol       Date:  2014-10-22       Impact factor: 5.590

Review 4.  Mitochondrial Abnormalities and Synaptic Damage in Huntington's Disease: a Focus on Defective Mitophagy and Mitochondria-Targeted Therapeutics.

Authors:  Neha Sawant; Hallie Morton; Sudhir Kshirsagar; Arubala P Reddy; P Hemachandra Reddy
Journal:  Mol Neurobiol       Date:  2021-09-14       Impact factor: 5.590

Review 5.  The ubiquitin-proteasome pathway in Huntington's disease.

Authors:  Steven Finkbeiner; Siddhartha Mitra
Journal:  ScientificWorldJournal       Date:  2008-04-20

6.  Temporal separation of aggregation and ubiquitination during early inclusion formation in transgenic mice carrying the Huntington's disease mutation.

Authors:  Belvin Gong; Catherine Kielar; A Jennifer Morton
Journal:  PLoS One       Date:  2012-07-24       Impact factor: 3.240

7.  Polyglutamine disruption of the huntingtin exon 1 N terminus triggers a complex aggregation mechanism.

Authors:  Ashwani K Thakur; Murali Jayaraman; Rakesh Mishra; Monika Thakur; Veronique M Chellgren; In-Ja L Byeon; Dalaver H Anjum; Ravindra Kodali; Trevor P Creamer; James F Conway; Angela M Gronenborn; Ronald Wetzel
Journal:  Nat Struct Mol Biol       Date:  2009-03-08       Impact factor: 15.369

8.  Monomeric, oligomeric and polymeric proteins in huntington disease and other diseases of polyglutamine expansion.

Authors:  Guylaine Hoffner; Philippe Djian
Journal:  Brain Sci       Date:  2014-03-03
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.